Traditional culture techniques often underestimate the composition and diversity of bacteria, especially those that inhabit the lower urinary tract. Several groups have used 16S rRNA gene sequence analysis of bacteria in urine to document the presence of a bacterial community (microbiome) in the lower urinary tract of adult women and men. By using 16S rRNA gene sequence analysis on catheterized urine samples obtained at baseline from patient-participants in a randomized clinical trial for the treatment of urgency urinary incontinence, we more thoroughly describe the previously detected female urinary microbiome.
I N T R O D U C T I O N : M E T H O D S (subject/specimen acquisition) :
Traditional culture techniques often underestimate the composition and diversity of bacteria, especially those that inhabit the lower urinary tract. Several groups have used 16S rRNA gene sequence analysis of bacteria in urine to document the presence of a bacterial community (microbiome) in the lower urinary tract of adult women and men. By using 16S rRNA gene sequence analysis on catheterized urine samples obtained at baseline from patient-participants in a randomized clinical trial for the treatment of urgency urinary incontinence, we more thoroughly describe the previously detected female urinary microbiome.
The Anticholinergic Versus Botulinum Toxin A Comparison (ABC) Trial was a 10-center, double-blind, double-placebo-controlled randomized trial in which women received either one intra-detrusor injection of 100 U of onabotulinumtoxin A and daily oral placebo or daily oral anticholinergic medication and one intradetrusor injection of saline. The full methods of the trial and the primary outcome have been published. The primary outcome was reduction from baseline in mean episodes of urgency urinary incontinence per day over the 6-month period, as recorded in 3-day diaries submitted monthly. Secondary outcomes included complete resolution of urgency urinary incontinence, quality of life, use of catheters, and adverse events including urinary tract infections. Urinary tract infection (UTI) was defined as a positive culture with greater than 105 colony-forming units of a known uropathogen or treatment with antibiotic for UTI at any point between randomization and 6 months. Following treatment, intermittent catheterization was recommended if post void residual was either >300mL or >150mL with "moderate" to "quite a bit" of bother associated with incomplete voiding.
DNA isolation, Library generation and MiSeq sequencing::
Genomic DNA was extracted from 1 ml of urine using previously validated protocols. Variable region 4 (V4) of the bacterial 16S rRNA gene was amplified via a two-step nested polymerase chain reaction (PCR) protocol, using modified universal primers 515F and 806R, as previously described. Extraction negative controls (no urine) and PCR negative controls (no template) were included to assess the contribution of extraneous DNA from reagents. The final PCR product was purified from unincorporated nucleotides and primers using Qiaquick PCR purification kit (Qiagen, Valencia, CA) and Agencourt AMPure XP-PCR magnetic beads (Beckman coulter) and the samples were normalized to equal DNA concentration, as determined by Nanodrop spectroscopy (Thermo Scientific, Waltham, MA). The sample library and the PhiX sequencing control library (Illumina) were denatured and added to the 2x250 bp sequencing reagent cartridge, according to the manufacturer's instructions (Illumina).
DNA Sequence Analysis:
The Illumina MiSeq post-sequencing software preprocessed sequences by removing primers and sample indices. All samples were processed in duplicate and were dichotomously characterized as sequence-positive and sequence-negative. A sequence-negative sample was one in which DNA was not amplified in either technical replica.
To display the average sequence abundance for each sample, a histogram was produced, color-coded by bacterial taxa. Next, Euclidean distance was calculated between samples and the complete method was used for hierarchical clustering. The resulting dendrogram was divided into 8 groups that clustered together. These groups, which we call urotypes, along with the sequence-negative group, were then compared to participant demographics, symptoms at baseline and clinical outcomes. Sequence-positive subjects responded better to treatment with a larger decrease in baseline urgency urinary incontinence episodes (-4.4 vs. -3.3, p=0.0013) , with no evidence of interaction with treatment group (p=0.92). Sequence-positive subjects also were less likely to develop urinary tract infection after initiation of study incontinence treatment (9% vs. 27%, p=0.0011) ( 37.5 -9.0 -96.7) 36.9 (-28.8 -93.8) In the sequence-positive urines, 8 major groups (urotypes) were identified. A single bacterial genus or family dominated most urotypes (i.e., >45% total sequence reads) (Figure 1 ). Nearly half (45%) were dominated by the genus Lactobacillus, followed by Gardnerella (17%), Gardnerella/Prevotella (9%), Enterobacteriaceae (9%), Staphylococcus (3%), Aerococcus (2%) and Bifidobacterium (2%). The remaining urotype was called Diverse to signify those (13%) without a dominant genus.
R E S U L T S :

R E S U L T S C O N T I N U E D :
Figure 1 
C O N C L U S I O N S :
Women with urgency urinary incontinence are a heterogeneous population on the basis of their baseline sequence status and/or urotype. Nearly half of female trial participants with urgency urinary incontinence, without evidence of clinical infection, had a urotype that was typically dominated by a single genus, most often Lactobacillus or Gardnerella. These bacterial communities appear to have clinical relationships with baseline urgency incontinence symptoms, response to treatment and risk for post-treatment urinary tract infection. Our findings suggest that previously undetected bacteria in the bladder of women affect urgency urinary incontinence, providing expanded opportunities for prevention and improved treatment approaches for urgency urinary incontinence. 
